James Loerop, Chief Business Officer at Aclaris Therapeutics, Inc. (ACRS), bought 14,705 shares at $6.80 ($100K) on 2023-08-28, disclosed to the SEC on 2023-08-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |